ArticleEClinicalMedicine2025

Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in France.

Charlotte Ocana de Sentuary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.